Log in

NASDAQ:APYX - Apyx Medical Stock Price, Forecast & News

$8.08
+0.03 (+0.37 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$7.96
Now: $8.08
$8.20
50-Day Range
$6.35
MA: $7.29
$8.05
52-Week Range
$3.55
Now: $8.08
$8.89
Volume58,349 shs
Average Volume98,822 shs
Market Capitalization$276.09 million
P/E RatioN/A
Dividend YieldN/A
Beta0.16
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APYX
CUSIPN/A
CIKN/A
Phone727-384-2323

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$16.69 million
Book Value$2.64 per share

Profitability

Net Income$64.01 million

Miscellaneous

Employees222
Market Cap$276.09 million
Next Earnings Date3/11/2020 (Estimated)
OptionableOptionable

Receive APYX News and Ratings via Email

Sign-up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.


Apyx Medical (NASDAQ:APYX) Frequently Asked Questions

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

How were Apyx Medical's earnings last quarter?

Apyx Medical Corp (NASDAQ:APYX) announced its quarterly earnings results on Monday, November, 11th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.18) by $0.05. The company earned $7.58 million during the quarter, compared to the consensus estimate of $6.78 million. Apyx Medical had a negative return on equity of 20.25% and a negative net margin of 66.77%. The firm's revenue for the quarter was up 106.3% compared to the same quarter last year. View Apyx Medical's Earnings History.

When is Apyx Medical's next earnings date?

Apyx Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Apyx Medical.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$27.4-27.9 million, compared to the consensus revenue estimate of $$26.97 million.

What price target have analysts set for APYX?

3 Wall Street analysts have issued 1 year price targets for Apyx Medical's stock. Their forecasts range from $8.00 to $10.00. On average, they anticipate Apyx Medical's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 11.4% from the stock's current price. View Analyst Price Targets for Apyx Medical.

What is the consensus analysts' recommendation for Apyx Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Apyx Medical.

Has Apyx Medical been receiving favorable news coverage?

News coverage about APYX stock has trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Apyx Medical earned a news impact score of -1.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Apyx Medical.

Are investors shorting Apyx Medical?

Apyx Medical saw a increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,320,000 shares, an increase of 35.4% from the October 31st total of 974,700 shares. Based on an average trading volume of 82,000 shares, the short-interest ratio is currently 16.1 days. Currently, 4.4% of the shares of the stock are short sold. View Apyx Medical's Current Options Chain.

Who are some of Apyx Medical's key competitors?

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), Main Street Capital (MAIN), SPDR S&P 500 ETF Trust (SPY), Amgen (AMGN), Kraft Heinz (KHC), Invesco QQQ Trust (QQQ), Alibaba Group (BABA), Bank of America (BAC) and CVS Health (CVS).

Who are Apyx Medical's key executives?

Apyx Medical's management team includes the folowing people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 53)
  • Ms. Tara H. Semb, CFO, Treasurer & Sec. (Age 49)
  • Mr. Moshe Citronowicz, Sr. VP (Age 66)
  • Mr. Todd Hornsby, Exec. VP (Age 43)

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include State Street Corp (1.63%), Taylor Frigon Capital Management LLC (1.30%), Perkins Capital Management Inc. (0.59%), P.A.W. Capital Corp (0.29%), Squarepoint Ops LLC (0.14%) and Creative Financial Designs Inc. ADV (0.14%).

Which institutional investors are selling Apyx Medical stock?

APYX stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Squarepoint Ops LLC, P.A.W. Capital Corp, Taylor Frigon Capital Management LLC, Barclays PLC and Creative Financial Designs Inc. ADV.

Which institutional investors are buying Apyx Medical stock?

APYX stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Metropolitan Life Insurance Co NY, Rhumbline Advisers and Frisch Financial Group Inc..

How do I buy shares of Apyx Medical?

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $8.08.

How big of a company is Apyx Medical?

Apyx Medical has a market capitalization of $276.09 million and generates $16.69 million in revenue each year. The company earns $64.01 million in net income (profit) each year or ($0.29) on an earnings per share basis. Apyx Medical employs 222 workers across the globe.View Additional Information About Apyx Medical.

What is Apyx Medical's official website?

The official website for Apyx Medical is http://www.apyxmedical.com/.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]


MarketBeat Community Rating for Apyx Medical (NASDAQ APYX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  74
MarketBeat's community ratings are surveys of what our community members think about Apyx Medical and other stocks. Vote "Outperform" if you believe APYX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APYX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel